Search research articles
Contact Us
Filters
Showing results (91-100 of 125) with videos related to
Page
of 13
Sort By:
Journal of Hepatology
|
November 30, 2014
The association of liver enzymes with biomarkers of subclinical myocardial damage and structural heart disease
Mariana Lazo, Jonathan Rubin, Jeanne M Clark, et al.
CNS Drugs
|
August 13, 2025
Viloxazine Extended-Release Capsules in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Results of a Long-Term, Phase 3, Open-Label Extension Trial
Robert L Findling, Alain Katic, Michael Liebowitz, et al.
Clinical Biochemistry
|
March 16, 2016
Determinants of minimal elevation in high-sensitivity cardiac troponin T in the general population
Jonathan Rubin, Kunihiro Matsushita, Mariana Lazo, et al.
International Journal of Clinical Practice
|
May 10, 2021
Evaluating the likelihood to be helped or harmed after treatment with viloxazine extended-release in children and adolescents with attention-deficit/hyperactivity disorder
Azmi Nasser, Alisa R Kosheleff, Joseph T Hull, et al.
Journal of Child and Adolescent Psychopharmacology
|
February 18, 2021
Translating Attention-Deficit/Hyperactivity Disorder Rating Scale-5 and Weiss Functional Impairment Rating Scale-Parent Effectiveness Scores into Clinical Global Impressions Clinical Significance Levels in Four Randomized Clinical Trials of SPN-812 (Viloxazine Extended-Release) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
Azmi Nasser, Alisa R Kosheleff, Joseph T Hull, et al.
Annals of Surgical Oncology
|
February 3, 2025
Protective Factors Associated with Normal Lymphatic Function After Axillary Lymph Node Dissection for Breast Cancer Treatment
Janet C Coleman-Belin, Jonathan Rubin, Lillian A Boe, et al.
Circulation
|
August 24, 2014
Diabetes mellitus, prediabetes, and incidence of subclinical myocardial damage
Elizabeth Selvin, Mariana Lazo, Yuan Chen, et al.
Annals of Surgical Oncology
|
October 8, 2025
ASO Visual Abstract: Are We Underestimating Breast Cancer-Related Lymphedema? The Impact of Diagnostic Thresholds and Compression Therapy
Benjamin D Wagner, Jonathan Rubin, Lillian A Boe, et al.
Blood Purification
|
February 10, 2015
Quantitative lung ultrasound comet measurement: method and initial clinical results
William F Weitzel, James Hamilton, Xianglong Wang, et al.
Annals of Surgical Oncology
|
September 18, 2025
Are We Underestimating Breast Cancer-Related Lymphedema? The Impact of Diagnostic Thresholds and Compression Therapy
Benjamin D Wagner, Jonathan Rubin, Lillian A Boe, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 125) with videos related to
Sort By:
Page
of 13
Journal of Hepatology
|
November 30, 2014
The association of liver enzymes with biomarkers of subclinical myocardial damage and structural heart disease
Mariana Lazo, Jonathan Rubin, Jeanne M Clark, et al.
CNS Drugs
|
August 13, 2025
Viloxazine Extended-Release Capsules in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Results of a Long-Term, Phase 3, Open-Label Extension Trial
Robert L Findling, Alain Katic, Michael Liebowitz, et al.
Clinical Biochemistry
|
March 16, 2016
Determinants of minimal elevation in high-sensitivity cardiac troponin T in the general population
Jonathan Rubin, Kunihiro Matsushita, Mariana Lazo, et al.
International Journal of Clinical Practice
|
May 10, 2021
Evaluating the likelihood to be helped or harmed after treatment with viloxazine extended-release in children and adolescents with attention-deficit/hyperactivity disorder
Azmi Nasser, Alisa R Kosheleff, Joseph T Hull, et al.
Journal of Child and Adolescent Psychopharmacology
|
February 18, 2021
Translating Attention-Deficit/Hyperactivity Disorder Rating Scale-5 and Weiss Functional Impairment Rating Scale-Parent Effectiveness Scores into Clinical Global Impressions Clinical Significance Levels in Four Randomized Clinical Trials of SPN-812 (Viloxazine Extended-Release) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
Azmi Nasser, Alisa R Kosheleff, Joseph T Hull, et al.
Annals of Surgical Oncology
|
February 3, 2025
Protective Factors Associated with Normal Lymphatic Function After Axillary Lymph Node Dissection for Breast Cancer Treatment
Janet C Coleman-Belin, Jonathan Rubin, Lillian A Boe, et al.
Circulation
|
August 24, 2014
Diabetes mellitus, prediabetes, and incidence of subclinical myocardial damage
Elizabeth Selvin, Mariana Lazo, Yuan Chen, et al.
Annals of Surgical Oncology
|
October 8, 2025
ASO Visual Abstract: Are We Underestimating Breast Cancer-Related Lymphedema? The Impact of Diagnostic Thresholds and Compression Therapy
Benjamin D Wagner, Jonathan Rubin, Lillian A Boe, et al.
Blood Purification
|
February 10, 2015
Quantitative lung ultrasound comet measurement: method and initial clinical results
William F Weitzel, James Hamilton, Xianglong Wang, et al.
Annals of Surgical Oncology
|
September 18, 2025
Are We Underestimating Breast Cancer-Related Lymphedema? The Impact of Diagnostic Thresholds and Compression Therapy
Benjamin D Wagner, Jonathan Rubin, Lillian A Boe, et al.
Page
of 13